ERAMOL (UK) LTD
Significant control: Eramol Group Holdings Ltd (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Eramol (UK) Ltd: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Eramol (UK) Ltd sell?
Registered activity: Manufacture of basic pharmaceutical products (SIC 21100). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
ERAMOL (UK) LTD is an active private limited company (company number 08681617) incorporated on 9 September 2013, registered in Sevenoaks. Its registered activity is manufacture of basic pharmaceutical products (SIC 21100). Latest abridged accounts cover the period ending 31 December 2025, showing net assets of £5.53m and cash of £1.45m, with 44 employees on average. As abridged accounts, no profit and loss account is filed, so turnover and profit are not public.
By net assets it sits in the top quarter of 661 comparable companies in the UK (median £265, upper quartile £89k).
Ownership and control
- Eramol Group Holdings Ltd
- owns 75–100% of shares
- holds 75–100% of voting rights
- Mrs Caroline Mollison
- owns 25–50% of shares
- Mr Ka Yan Che
- owns 25–50% of shares
- Ms Sin Yee Sham
- owns 25–50% of shares
- Mr Peter Mollison
- owns 25–50% of shares
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 9 September 201313 yrs ago
- Next accounts due
- 30 September 2027in 340 days
- Confirmation statement due
- 23 September 2027in 333 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 21100
- Manufacture of basic pharmaceutical products
- Accounts type
- Unaudited Abridged
- Size band
- SmallCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 December 2025 | £5.53m | £1.45m | £1.16m | £277k | — | — | 44 |
| 1 January 2025 | — | — | — | — | — | — | — |
| 31 December 2024 | £5.58m | £2.68m | £1.67m | £760k | — | — | 40 |
| 1 January 2024 | — | — | — | — | — | — | — |
| 31 December 2023 | £4.68m | £2.99m | £1.73m | £932k | — | — | 39 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Filing and accounts signals
- Net assets above zeroNet assets £5,526,911 at 31 December 2025
- Current assets at least 1.5× creditors within one yearCurrent ratio 9.92
- Cash at bank of £50,000 or moreCash £1,449,534
- Three or more accounting periods on record5 periods on record
- Incorporated five or more years agoIncorporated 9 September 2013
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Next accounts duein 340 days
- Confirmation statement duein 333 days
- Accounts period endNet assets £5.53m · abridged accounts
- Accounts period end
- Accounts period endNet assets £5.58m · abridged accounts
- Accounts period end
- Accounts period endNet assets £4.68m · abridged accounts
- Incorporated
Similar companies in Kent
- FINE TREATMENT LIMITEDSevenoaks · inc. Apr 2014
- CHARIS CONSULT LIMITEDMaidstone · inc. Oct 2014
- LEPTREX LTD.Rye · inc. Sept 2011
- PHARMA-X CONSULTANCY LTDSt Leonards On Sea · inc. Apr 2011
- ASYMCHEM LIMITEDSandwich · inc. Feb 2017
- PURE PEACE LTDTonbridge · inc. Feb 2017
All companies incorporated on 9 September 2013 · in Sept 2013.
Reminders for ERAMOL (UK) LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.